Exclusion of Intra-atrial Thrombus Before Catheter Ablation (EXTRALUCID)
Diagnostic Accuracy of the ATE Score for the Exclusion of Intra-atrial Thrombi Before Catheter Ablation of Atrial Fibrillation: a Confirmatory Study
Sponsor: Diagnostica Stago
This observational or N/A phase trial investigates Atrial Fibrillation and Thrombi and is currently completed. Diagnostica Stago leads this study, which shows 14 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2024 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Jan 2024 [monthly]
Completed
▶ Show 9 earlier versions
-
Feb 2021 — Dec 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Mar 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Feb 2019 [monthly]
Not Yet Recruiting
-
May 2018 — Sep 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — May 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Diagnostica Stago
- Groupe Hospitalier de la Rochelle Ré Aunis
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aix-en-Provence, France , Annecy, France , Brest, France , Geneva, Switzerland , La Rochelle, France , Le Mans, France , Metz, France , Nantes, France , Nîmes, France , Paris, France and 5 more locations